Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

News Conference News TCT 2017

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

November 08, 2017

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

News Conference News TCT 2017

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

November 01, 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

The NOTION 2 Low-risk Trial in Younger Patients

Presentation TCT 2017

The NOTION 2 Low-risk Trial in Younger Patients

Presenter: Lars Sondergaard

October 30, 2017

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores – Potential Benefits and Harms

Presentation TCT 2017

Germany Presents: Future Perspective - TAVR Compared to Surgical Valve Replacement in Patients With Low-Risk Scores Potential Benefits and Harms

Presenter: Dariusz Dudek, Martin Hudec, Michael Haude

October 30, 2017

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Presentation TCT 2017

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Craig R. Smith

October 30, 2017

TAVR in Low-Risk Patients

Presentation TCT 2017

TAVR in Low-Risk Patients

Presenter: Jeroen J. Bax, Axel Linke, Thomas Pilgrim

October 29, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.